GANGLIONEUROMA
Clinical trials for GANGLIONEUROMA explained in plain language.
Never miss a new study
Get alerted when new GANGLIONEUROMA trials appear
Sign up with your email to follow new studies for GANGLIONEUROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could spot hidden tumors more accurately
Diagnosis OngoingThis study tests a new type of PET/CT scan that uses a radioactive tracer called 68Ga-DOTATOC to find neuroendocrine tumors (NETs) and other related cancers. The scan targets a molecule found in high amounts on these tumor cells. Researchers want to see if this scan is safer and …
Matched conditions: GANGLIONEUROMA
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC
-
New scan may outshine standard test for Kids' rare tumors
Diagnosis OngoingThis study tests whether a special PET/CT scan using a radioactive tracer called 68Ga-DOTATATE can better detect neuroendocrine tumors (like neuroblastoma) in children and young adults up to age 30. The scan is compared to the standard MIBG scan to see which one more clearly show…
Matched conditions: GANGLIONEUROMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 12, 2026 13:40 UTC